Abstract
Extracellular vesicles (EVs) from human Explant-Derived Cells delivered directly to the atria at the time of open chest surgery reduce atrial fibrosis/inflammation and AF in a rat model of sterile pericarditis. But the minimally effective dose is not known, nor is it clear if this benefit is dependent on EV dose.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
